Valid
Massachusetts, United States · Biotechnology · 3 employees
VALID is transforming drug development by addressing high failure rates and inefficiencies caused by unreliable, non-translating research models. Our advanced hiPSC-derived models offer increased predictive validity, enabling more accurate and scalable drug discovery. With VALID Techbio 2.0, we provide better data, leading to better targets and, ultimately, successful drug development.
Funding history
- Funding Round — $6.9M — Jan 2025
Recent signals
- Jan 22, 2025: Raised $6.9M
See plans & pricing → Track Valid’s funding, hiring, and signals — with verified contacts — on Fundz.